Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU TopicsPharmacology

ICU · Pharmacology

Electrolyte Therapy — Sodium, Potassium, Magnesium, Calcium & Phosphate

Also known as Electrolyte therapy · Potassium replacement · Hypokalaemia · Hyperkalaemia · Hyponatraemia · Hypernatraemia · Magnesium · Calcium · Phosphate · Hypophosphataemia

Electrolyte therapy in the ICU: sodium (hyponatraemia - 3% saline 100 mL boluses for severe symptomatic, correction capped at 10 mmol/L in the first 24 h, osmotic demyelination risk; hypernatraemia - free-water deficit, correct no faster than 0.5 mmol/L per hour), potassium (rate-limited IV replacement, never a bolus, fix Mg first; hyperkalaemia - calcium stabilise, then insulin/dextrose with salbutamol shift, then remove), magnesium (MgSO4 4 g load + 1-2 g/h; hypermagnesaemia - stop infusion, dialysis if severe), calcium (treat the ionised fraction; hypocalcaemia - IV calcium for symptomatic; hypercalcaemia - hydration + bisphosphonate, zoledronate 4 mg), phosphate (hypophosphataemia - respiratory muscle weakness, IV replacement when severe, refeeding syndrome prevention with thiamine and electrolyte monitoring).

high51 referencesUpdated 1 Sept 202626 min readSource-verified · Sept 2026

Checked against its sources on 1 Sept 2026

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC
On this page
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC
The one-line exam answer

Electrolyte therapy in ICU runs on one rule: correct the rate, not just the number — and replete magnesium first, or potassium and calcium will not hold. Sodium: classify hyponatraemia by volume status, give 3% saline 100 mL boluses for seizures, and cap the rise at 10 mmol/L in the first 24 h (8 or less once symptoms resolve); hypernatraemia is a free-water deficit corrected at no more than 0.5 mmol/L per hour. Potassium: always a dilute, rate-limited, pump-controlled infusion — never a bolus; for hyperkalaemia go calcium, then shift, then remove.

[10][8][11][16]

Meet the patient

It is 3am. In bed 4, a 68-year-old woman on a thiazide and an SSRI, six days into a chest infection, seizes on the ward — her sodium is 112 mmol/L, deep in the severe range. In bed 7, a separate patient with acute kidney injury shows peaked T waves and a widening QRS on the monitor — potassium 7.1 mmol/L with ECG changes, an emergency by any criterion.[1][16]

Two patients, one question each. Bed 4 asks: how fast can I raise her sodium without destroying her pons? Bed 7 asks: what sequence keeps this heart on the monitor? Hold those two questions and the whole topic slots into place.[1]

ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References51ShowHide
  1. [1]Spasovski G, Vanholder R, Allolio B, et al Clinical practice guideline on diagnosis and treatment of hyponatraemia Intensive Care Med, 2014.PMID 24562549
  2. [2]Adrogué HJ, Madias NE Hyponatremia N Engl J Med, 2000.PMID 10824078
  3. [3]Adrogué HJ, Madias NE Hypernatremia N Engl J Med, 2000.PMID 10816188
  4. [4]Nyirenda MJ, Tang JI, Padfield PL, Seckl JR Hyperkalaemia BMJ, 2009.PMID 19854840
  5. [5]Mehanna HM, Moledina J, Travis J Refeeding syndrome: what it is, and how to prevent and treat it BMJ, 2008.PMID 18583681
  6. [6]Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia N Engl J Med, 2006.PMID 17105757
  7. [7]Spasovski G Hyponatraemia-treatment standard 2024 Nephrol Dial Transplant, 2024.PMID 39009016
  8. [8]Adrogué HJ, Tucker BM, Madias NE Diagnosis and Management of Hyponatremia: A Review JAMA, 2022.PMID 35852524
  9. [9]Sterns RH, Silver SM Complications and management of hyponatremia Curr Opin Nephrol Hypertens, 2016.PMID 26735146
  10. [10]Garrahy A, Dineen R, Hannon AM, et al Continuous Versus Bolus Infusion of Hypertonic Saline in the Treatment of Symptomatic Hyponatremia Caused by SIAD J Clin Endocrinol Metab, 2019.PMID 30882872
  11. [11]Chauhan K, Pattharanitima P, Patel N, et al Rate of Correction of Hypernatremia and Health Outcomes in Critically Ill Patients Clin J Am Soc Nephrol, 2019.PMID 30948456
  12. [12]Kitisin N, Raykateeraroj N, Hikasa Y, et al Systematic review and meta-analysis of the treatment of hypernatremia in adult hospitalized patients: impact on mortality, morbidity, and treatment-related side effects J Crit Care, 2025.PMID 39765195
  13. [13]Miller NE, Rushlow D, Stacey SK Diagnosis and Management of Sodium Disorders: Hyponatremia and Hypernatremia Am Fam Physician, 2023.PMID 37983699
  14. [14]Hoorn EJ, Zietse R Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines J Am Soc Nephrol, 2017.PMID 28174217
  15. [15]Chander S, Kumari R, Lohana AC, et al Urea to Treat Hyponatremia Due to Syndrome of Inappropriate Antidiuretic Hormone Secretion: A Systematic Review and Meta-Analysis Am J Kidney Dis, 2025.PMID 39362395
  16. [16]Kim HJ, Han SW Therapeutic approach to hyperkalemia Nephron, 2002.PMID 12401936
  17. [17]Moussavi K, Fitter S, Gabrielson SW, et al Management of Hyperkalemia With Insulin and Glucose: Pearls for the Emergency Clinician J Emerg Med, 2019.PMID 31084947
  18. [18]Allon M, Copkney C Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients Kidney Int, 1990.PMID 2266671
  19. [19]Putcha N, Allon M Management of hyperkalemia in dialysis patients Semin Dial, 2007.PMID 17897250
  20. [20]Nakatani K, Nakagami-Yamaguchi E, Shinoda Y, et al Improving the safety of high-concentration potassium chloride injection BMJ Open Qual, 2019.PMID 31259289
  21. [21]Huang CL, Kuo E Mechanism of hypokalemia in magnesium deficiency J Am Soc Nephrol, 2007.PMID 17804670
  22. [22]Unwin RJ, Luft FC, Shirley DG Pathophysiology and management of hypokalemia: a clinical perspective Nat Rev Nephrol, 2011.PMID 21278718
  23. [23]Brown RS Potassium homeostasis and clinical implications Am J Med, 1984.PMID 6388326
  24. [24]Israel RS Diabetic ketoacidosis Emerg Med Clin North Am, 1989.PMID 2509198
  25. [25]Karslioglu French E, Donihi AC, Korytkowski MT Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients BMJ, 2019.PMID 31142480
  26. [26]Lu JF, Nightingale CH Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles Clin Pharmacokinet, 2000.PMID 10803454
  27. [27]Van Laecke S Hypomagnesemia and hypermagnesemia Acta Clin Belg, 2019.PMID 30220246
  28. [28]Aal-Hamad AH, Al-Alawi AM, Kashoub MS, et al Hypermagnesemia in Clinical Practice Medicina (Kaunas), 2023.PMID 37512002
  29. [29]Pepe J, Colangelo L, Biamonte F, et al Diagnosis and management of hypocalcemia Endocrine, 2020.PMID 32367335
  30. [30]Fernandes C, Pereira L Hypocalcemia in critical care settings, from its clinical relevance to its treatment: A narrative review Anaesth Crit Care Pain Med, 2024.PMID 39395659
  31. [31]El-Hajj Fuleihan G, Clines GA, Hu MI, et al Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline J Clin Endocrinol Metab, 2023.PMID 36545746
  32. [32]Major P, Lortholary A, Hon J, et al Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials J Clin Oncol, 2001.PMID 11208851
  33. [33]Felsenfeld AJ, Levine BS Approach to treatment of hypophosphatemia Am J Kidney Dis, 2012.PMID 22863286
  34. [34]Matthews-Rensch K, Blackwood K, Lawlis D, et al The Australasian Society of Parenteral and Enteral Nutrition: Consensus statements on refeeding syndrome Nutr Diet, 2025.PMID 40090863
  35. [35]Friedli N, Stanga Z, Culkin A, et al Management and prevention of refeeding syndrome in medical inpatients: An evidence-based and consensus-supported algorithm Nutrition, 2018.PMID 29429529
  36. [36]Borriello R, Esposto G, Ainora ME, et al Understanding Refeeding Syndrome in Critically Ill Patients: A Narrative Review Nutrients, 2025.PMID 40507135
  37. [37]Liamis G, Hoorn EJ, Florentin M, et al An overview of diagnosis and management of drug-induced hypomagnesemia Pharmacol Res Perspect, 2021.PMID 34278747
  38. [38]Hu MI Hypercalcemia of Malignancy Endocrinol Metab Clin North Am, 2021.PMID 34774243
  39. [39]Ilardi A Diagnostic and therapeutic approach to hypernatremia Diagnosis (Berl), 2022.PMID 35918296
  40. [40]Wray JP, Bridwell RE, Schauer SG, et al The diamond of death: Hypocalcemia in trauma and resuscitation Am J Emerg Med, 2021.PMID 33421674
  41. [41]Bex S, Mollard F, Stirnemann J [Diagnosis and treatment of hypophosphatemia]. Rev Med Suisse, 2019.PMID 31617975
  42. [42]Cairo MS, Coiffier B, Reiter A, et al Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus Br J Haematol, 2010.PMID 20331465
  43. [43]Tisdale JE Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management Can Pharm J (Ott), 2016.PMID 27212965
  44. [44]Tzivoni D, Keren A, Cohen AM, et al Magnesium therapy for torsades de pointes Am J Cardiol, 1984.PMID 6695782
  45. [45]Christ-Crain M, Gaisl O Diabetes insipidus Presse Med, 2021.PMID 34718110
  46. [46]Sharma OP Hypercalcemia in granulomatous disorders: a clinical review Curr Opin Pulm Med, 2000.PMID 10958237
  47. [47]Albert A, Hinkel UP, Bohlender T, et al Paradoxical Inadequate Parathyroid Hormone Secretion Secondary to Severe Hypomagnesemia: A Review of the Literature Kidney Med, 2025.PMID 40740723
  48. [48]Jin A, Zhao M, Sun Y, et al Normal range of serum potassium, prevalence of dyskalaemia and associated factors in Chinese older adults: a cross-sectional study BMJ Open, 2020.PMID 33127634
  49. [49]Chakraborty A, Patel P, Can AS Calcium Gluconate StatPearls, 2026.PMID 32491395
  50. [50]Geldermann N, Dzimiera J, Fischer H, Christ M Acute hyperkalaemia in emergency care: evidence-based approaches Emerg Med J, 2026.PMID 41506858
  51. [51]Feldenzer KL, Sarno J Hypercalcemia of Malignancy J Adv Pract Oncol, 2018.PMID 31086686

Test yourself

Practise what you just read

  • 8 MCQs
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousDrug dosing in continuous renal replacement therapy (CRRT)PharmacologyNextICU antiarrhythmic drugs — comprehensive (Vaughan-Williams classification)Pharmacology